Enanta Pharmaceuticals reported $52.02M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Amgen AMGN:US $ 4.42B 680M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
AstraZeneca AZN:LN 10.23B 280M
Biocryst Pharmaceuticals BCRX:US $ 100.25M 374K
Biogen BIIB:US $ 2648.2M 727.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Clovis Oncology CLVS:US $ 91.52M 6.92M
Enanta Pharmaceuticals ENTA:US $ 52.02M 544K
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Insmed INSM:US $ 153.54M 10.6M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Johnson & Johnson JNJ:US $ 18.18B 616M
Karyopharm Therapeutics KPTI:US $ 82.59M 331K
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Marinus Pharmaceuticals MRNS:US $ 38.56M 7.66M
Merk MRK:US $ 9666M 666M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Novartis NOVN:VX 10.86B 895M
Novavax NVAX:US $ 668.88M 174.21M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Vital Therapies VTL:US $ 20.61M 825K
YTE INCY:US $ 656.97M 40.27M